Your browser doesn't support javascript.
loading
Contraindicated use of cisapride: impact of food and drug administration regulatory action.
Smalley, W; Shatin, D; Wysowski, D K; Gurwitz, J; Andrade, S E; Goodman, M; Chan, K A; Platt, R; Schech, S D; Ray, W A.
Affiliation
  • Smalley W; Department of Preventive Medicine, Medical Center North, A-1124, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
JAMA ; 284(23): 3036-9, 2000 Dec 20.
Article in En | MEDLINE | ID: mdl-11122591
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: United States Food and Drug Administration / Gastrointestinal Agents / Cisapride / Drug Labeling / Legislation, Drug Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: JAMA Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: United States Food and Drug Administration / Gastrointestinal Agents / Cisapride / Drug Labeling / Legislation, Drug Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: JAMA Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States